Hot News @ 中鋁放棄

 < Previous page   
Related Keyword:疫苗 , 專利 , 中鋁 , 目標價 , 大行報告
Related Concept:美國放棄新冠疫苗專利 , 疫苗股急挫康希諾
 
美國放棄新冠疫苗專利累港美疫苗股急挫康希諾、復星醫藥曾挫逾兩成、BioNTech盤前跌7% - 香港經濟日報- 即時新聞頻道- 即市財經- 股市 @ 2021-05-07T12:
美國拜登政府周三公布,美國將放棄新冠疫苗的知識產權專利,拖累本港上市的疫苗股今日急跌。負責引入輝瑞BioNTech疫苗到大中華區銷售的復星 ...
Keyword:疫苗 專利
Concept:美國放棄新冠疫苗專利 , 疫苗股急挫康希諾
【大行言論】摩通維持中鋁「中性」,削目標價32%至4.1元 @ 2011-10-27T04:
摩通發表研究報告,維持中鋁(2600-HK)「中性」評級,目標價由6元下調至4.1元。該行指出,中鋁第三季業績遜於預期,同時對鋁價的預期下調,將中鋁2011及2012財年的盈利預測,分別調低36%及21%。 該行指,中鋁第三季盈利按季翻倍,但本月開始鋁價出現顯著下跌,估計其良好
Keyword:中鋁 目標價 大行報告
Concept:
中鋁靚麗季報被指提前洩露 被港交所要求停牌 @ 2011-10-26T11:
靚麗「三季報」的背後,卻被指提前洩露。中國鋁業(3.9,0.07,1.83%)股份有限公司(601600.SH,02600.HK,簡稱中國鋁業)25日晚間披露的三季報顯示,當季淨利潤為5.55億元,超過了上半年兩個季度實現的淨利潤總和4.13億元;該公司去年第三季度淨虧損1.18億元。
Keyword:中鋁
Concept:
 < Previous page   

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.